Phillip Smith is the Director of Process Technology in the GSK Biopharm R&D Clinical
Manufacturing Pilot Plant in King of Prussia, PA. He leads a team of Scientists who conduct
technology transfer, facility fit, scale-up, and troubleshooting activities for drug substance
manufacturing processes. Other responsibilities include authoring of regulatory
submissions and industrialization of new processing technologies. Previous roles include
late-phase process development, characterization, and control strategy development for
downstream unit operations in GSK Biopharm R&D, and early-phase downstream process
development and technology transfer at Bristol-Myers Squibb. Phil is also a leader in
Quality by Design practice within GSK and a member of the Biopharm Sustainability Team.
He regularly presents at industry conferences and participates in various industry
consortia. Phil received B.S. and M.S. degrees in Chemical Engineering from Brigham
Young University, and a Ph.D. degree in Chemical Engineering from Stanford University.